Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma

Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma

<p>Abstract</p> <p>Background</p> <p>Rosiglitazone (ROZ) and glimepiride (GLM) are antidiabetic agents used in the treatment of type 2 diabetes mellitus. A survey of the literature reveals that only one spectrophotometric method has been reported for the simultaneous de...

Full description

Bibliographic Details
Main Authors: El-Enany Nahed M, Abdelal Amina A, Belal Fathalla F, Itoh Yoshinori I, Nakamura Mitsuhiro N
Format: Article
Language:English
Published: BMC 2012-01-01
Series:Chemistry Central Journal
Subjects:
HPLC
rosiglitazone (ROS)
glimepiride (GLM)
human plasma
Online Access:http://journal.chemistrycentral.com/content/6/1/9

Internet

http://journal.chemistrycentral.com/content/6/1/9

Similar Items